Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2026-05-22 18:22:11 ET · period of report 2026-05-20 · accession 0002012524-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-22 18:22 | 2026-05-20 | TBPH | Miller Aine | SVP, DEV, HEAD OF IRE OFFICE | F - Tax | $16.55 | -6,827 | 177.3K | -4% | -$113.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-05-20 | F | D | 6,827 | $16.55 | 177,334 | D | — | — | (F1) Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |